FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014136680> ?p ?o ?g. }

• W2014136680 endingPage "6" @default.
• W2014136680 startingPage "1" @default.
• W2014136680 abstract "Vaginal infection and inflammation with or without vulvar involvement are very common gynecologicaly clinical conditions associated with morbidity and reduced quality of life. Vaginal infections are commonly treated with causal antimicrobial treatments. In addition to specific antimicrobial treatment, anti-inflammatory therapy, both systemic or topical (vaginal douche), could be useful in the integrated treatment approach of these conditions reducing symptoms and speeding up the recovery in vulvovaginitis. Ibuprofen is a well-known effective and well-tolerated anti-COX (anti-COX1 and COX2) compound. In addition, several in vitro studies suggest that Ibuprofen shares antimicrobial and antifungal activities. Ibuprofen isobutanolammonium (Ib-isb) (Ginenorm) is a soluble salt from formulation suitable for external and intravaginal use. This salt completely dissociates in aqueous solution. Ib-isob is available in sachet and vaginal douche pharmaceutical formulations. Clinical efficacy of Ib-isob has been documented in 10 clinical studies (6 controlled and 4 open trials) which have enrolled in total 399 women with vulvovaginitis. The six controlled clinical trials were performed both versus placebo (2 studies) or versus active comparators such as benzydamine. In these studied, Ib-Isb has been used in general for 7 consecutive days with a twice application daily regimen at the dose of 1 g per application. Topical application of Ib-isob induced a marked and rapid reduction in signs (erythema, oedema) and symptoms (itching and burning sensation) of vulvovaginitis. In head-to-head studies carried out in comparison with other topical products, Ib-isob induced a more rapid reduction in both subjective and objective symptoms. In particular a remarkable significant improvement of all the symptoms has been observed in the group of patients treated with Ib-isob in comparison with women receiving benzydamine. The clinical data available for Ib-isob confirm that this salt, specifically developed for gynecological use, is effective and well tolerated in vulvovaginal inflammation conditions. Efficacy of Ib-isob was greater in comparison with commonly used products. Ibuprofen-isob may be considered a useful and effective tool for the topical treatment of nonspecific vaginal diseases." @default.
• W2014136680 created "2016-06-24" @default.
• W2014136680 creator A5046175437 @default.
• W2014136680 creator A5079787548 @default.
• W2014136680 date "2012-07-09" @default.
• W2014136680 modified "2023-10-06" @default.
• W2014136680 title "Vaginal Use of Ibuprofen Isobutanolammonium (Ginenorm): Efficacy, Tolerability, and Pharmacokinetic Data: A Review of Available Data" @default.
• W2014136680 cites W1965135172 @default.
• W2014136680 cites W1981816788 @default.
• W2014136680 cites W1996351236 @default.
• W2014136680 cites W2000725199 @default.
• W2014136680 cites W2003601582 @default.
• W2014136680 cites W2020021851 @default.
• W2014136680 cites W2020049581 @default.
• W2014136680 cites W2052546313 @default.
• W2014136680 cites W2075921209 @default.
• W2014136680 cites W2084289720 @default.
• W2014136680 cites W2086661067 @default.
• W2014136680 cites W2089180950 @default.
• W2014136680 cites W2104379105 @default.
• W2014136680 cites W2145857627 @default.
• W2014136680 cites W2149253174 @default.
• W2014136680 cites W2158052093 @default.
• W2014136680 cites W2160616339 @default.
• W2014136680 cites W2328387533 @default.
• W2014136680 cites W2331230206 @default.
• W2014136680 cites W2987813806 @default.
• W2014136680 cites W4211042503 @default.
• W2014136680 cites W4248428734 @default.
• W2014136680 cites W80724400 @default.
• W2014136680 doi "https://doi.org/10.5402/2012/673131" @default.
• W2014136680 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3400361" @default.
• W2014136680 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22844609" @default.
• W2014136680 hasPublicationYear "2012" @default.
• W2014136680 type Work @default.
• W2014136680 sameAs 2014136680 @default.
• W2014136680 citedByCount "10" @default.
• W2014136680 countsByYear W20141366802016 @default.
• W2014136680 countsByYear W20141366802017 @default.
• W2014136680 countsByYear W20141366802019 @default.
• W2014136680 countsByYear W20141366802020 @default.
• W2014136680 countsByYear W20141366802021 @default.
• W2014136680 countsByYear W20141366802023 @default.
• W2014136680 crossrefType "journal-article" @default.
• W2014136680 hasAuthorship W2014136680A5046175437 @default.
• W2014136680 hasAuthorship W2014136680A5079787548 @default.
• W2014136680 hasBestOaLocation W20141366801 @default.
• W2014136680 hasConcept C126322002 @default.
• W2014136680 hasConcept C142724271 @default.
• W2014136680 hasConcept C16005928 @default.
• W2014136680 hasConcept C178790620 @default.
• W2014136680 hasConcept C185592680 @default.
• W2014136680 hasConcept C197934379 @default.
• W2014136680 hasConcept C204787440 @default.
• W2014136680 hasConcept C27081682 @default.
• W2014136680 hasConcept C2778375690 @default.
• W2014136680 hasConcept C2779121184 @default.
• W2014136680 hasConcept C2779766023 @default.
• W2014136680 hasConcept C2779923671 @default.
• W2014136680 hasConcept C2779944601 @default.
• W2014136680 hasConcept C2781413609 @default.
• W2014136680 hasConcept C4937899 @default.
• W2014136680 hasConcept C501593827 @default.
• W2014136680 hasConcept C535046627 @default.
• W2014136680 hasConcept C64778159 @default.
• W2014136680 hasConcept C71924100 @default.
• W2014136680 hasConcept C86803240 @default.
• W2014136680 hasConcept C89423630 @default.
• W2014136680 hasConcept C98274493 @default.
• W2014136680 hasConceptScore W2014136680C126322002 @default.
• W2014136680 hasConceptScore W2014136680C142724271 @default.
• W2014136680 hasConceptScore W2014136680C16005928 @default.
• W2014136680 hasConceptScore W2014136680C178790620 @default.
• W2014136680 hasConceptScore W2014136680C185592680 @default.
• W2014136680 hasConceptScore W2014136680C197934379 @default.
• W2014136680 hasConceptScore W2014136680C204787440 @default.
• W2014136680 hasConceptScore W2014136680C27081682 @default.
• W2014136680 hasConceptScore W2014136680C2778375690 @default.
• W2014136680 hasConceptScore W2014136680C2779121184 @default.
• W2014136680 hasConceptScore W2014136680C2779766023 @default.
• W2014136680 hasConceptScore W2014136680C2779923671 @default.
• W2014136680 hasConceptScore W2014136680C2779944601 @default.
• W2014136680 hasConceptScore W2014136680C2781413609 @default.
• W2014136680 hasConceptScore W2014136680C4937899 @default.
• W2014136680 hasConceptScore W2014136680C501593827 @default.
• W2014136680 hasConceptScore W2014136680C535046627 @default.
• W2014136680 hasConceptScore W2014136680C64778159 @default.
• W2014136680 hasConceptScore W2014136680C71924100 @default.
• W2014136680 hasConceptScore W2014136680C86803240 @default.
• W2014136680 hasConceptScore W2014136680C89423630 @default.
• W2014136680 hasConceptScore W2014136680C98274493 @default.
• W2014136680 hasLocation W20141366801 @default.
• W2014136680 hasLocation W20141366802 @default.
• W2014136680 hasLocation W20141366803 @default.
• W2014136680 hasLocation W20141366804 @default.
• W2014136680 hasOpenAccess W2014136680 @default.
• W2014136680 hasPrimaryLocation W20141366801 @default.
• W2014136680 hasRelatedWork W1629037931 @default.

• next